Last Updated:
Name Designation Appointment Date Status
Anilkumar Shridhar Mulye

Appointed as Director since September 2024

Director 16-Sep-2024 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Shraddha Vinayak Dhamankar

Appointed as Director since January 2001

Director 01-Jan-2001 Current

People Timeline

Explore the timeline of key personnel in Enem Nostrum Remedies Private Limited's leadership journey.

Loading...
Contact Details
  • Address 201-204, Gayatri Commercial Complex, Behind Mittal Ind.Estate, Kurla-Andheri Road, Andheri, (E),, Mumbai Maharashtra, 400059, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
How can I contact Enem Nostrum Remedies Private Limited?
You can contact Enem Nostrum Remedies Private Limited through their registered address at 201-204, Gayatri Commercial Complex, Behind Mittal Ind.Estate, Kurla-Andheri Road, Andheri, (E),, Mumbai Maharashtra, 400059, India, or via their website at enemnostrum.com. Social media links are also provided where applicable.
Who are the current directors of Enem Nostrum Remedies Private Limited?
The current directors of Enem Nostrum Remedies Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • Anilkumar Shridhar Mulye
  • SHRADDHA VINAYAK DHAMANKAR
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available